Aura Biosciences, Inc. (AURA) vs BlossomHill Therapeutics, Inc. (BLSM)

A side-by-side comparison of Aura Biosciences, Inc. and BlossomHill Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aura Biosciences, Inc. logo
AURA
Aura Biosciences, Inc.
$644M
$6.23HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
BlossomHill Therapeutics, Inc. logo
BLSM
BlossomHill Therapeutics, Inc.
$554M
$19.06HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT

Total return — AURA vs BLSM

growth of $100 · dividends reinvested · last 1y
AURA -13.4% (-13.4%/yr)BLSM +24.6% (+24.6%/yr)BLSM compounded faster over this window
80100120140160Start $100$87$125
AURA BLSM

AURA vs BLSM: by the numbers

  • •AURA is the larger company ($644M vs $554M market cap).

Metrics side by side

Valuation

MetricAURABLSM
P/B ratio2.04N/A

Profitability

MetricAURABLSM
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-41.56%N/A
ROIC-42.02%-43.41%

Go deeper

Full AURA analysisFull BLSM analysisInteractive comparison tool

Dig into the metrics

Aura Biosciences ROEBlossomHill Therapeutics ROEAura Biosciences operating marginBlossomHill Therapeutics operating marginAura Biosciences revenue growthBlossomHill Therapeutics revenue growthAura Biosciences free cash flowBlossomHill Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.